Modified Glasgow prognostic score (mGPS), which is defined based on the serum concentrations of C-reactive protein (CRP) and albumin [6], has been identified as a prognostic predictor in various malignancies, including ESCC [7–10]. This evidence concerns the gene CRP and esophageal squamous cell carcinoma.